Further processing options
Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer
Saved in:
Journal Title: | JNCI Journal of the National Cancer Institute |
---|---|
Authors and Corporations: | |
In: | JNCI Journal of the National Cancer Institute, 100, 2008, 6, p. 445-446 |
Type of Resource: | E-Article |
Language: | English |
published: |
Oxford University Press (OUP)
|
Subjects: |